Medigen Biotechnology (ROCO:3176) Other Gross PPE : NT$2,000 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Medigen Biotechnology Other Gross PPE?

Medigen Biotechnology's Other Gross PPE for the quarter that ended in Mar. 2024 was NT$2,000 Mil.

Medigen Biotechnology's quarterly Other Gross PPE declined from Sep. 2023 (NT$2,122 Mil) to Dec. 2023 (NT$2,043 Mil) and declined from Dec. 2023 (NT$2,043 Mil) to Mar. 2024 (NT$2,000 Mil).

Medigen Biotechnology's annual Other Gross PPE increased from Dec. 2021 (NT$2,189 Mil) to Dec. 2022 (NT$2,198 Mil) but then declined from Dec. 2022 (NT$2,198 Mil) to Dec. 2023 (NT$2,043 Mil).

Medigen Biotechnology Other Gross PPE Historical Data

The historical data trend for Medigen Biotechnology's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigen Biotechnology Other Gross PPE Chart

Medigen Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

2,540.27

2,166.04

2,189.33

2,197.68

2,043.21

Medigen Biotechnology Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Gross PPE	Get a 7-Day Free Trial															2,175.79	2,153.73	2,121.88	2,043.21	2,000.34

Medigen Biotechnology Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Medigen Biotechnology (ROCO:3176) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Biotechnology Corp (ROCO:3176) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yuancyu Street, 14F, Building No.3,, Nangang District, Taipei, TWN, 11560

Website

https://www.medigen.com.tw

Medigen Biotechnology Corp is a biopharmaceutical company primarily engaged in new drug development, drug discovery, molecular diagnostics, vaccine, and generic drugs. The new drug development business focuses mainly on the clinical stage of drug development and includes PI-88 MUPAFOSTAT for the treatment of liver cancer and OBP-301 treatment using adenovirus targeted to cancer cells only. Drug discovery includes the development of human-native mAbs for therapeutic applications related to infectious diseases. Generic drugs include pharmaceuticals for infectious diseases (antibiotics), contraceptives, nutrition milk powder, vitamin C tablets, dermatologic agents, and eye care products.

Medigen Biotechnology (ROCO:3176) Headlines

No Headlines